India Radiotherapy Devices Market Assessment, By Product [External Beam Radiation Therapy Device, Internal Beam Radiation Therapy Device, Others], By Application [Lung Cancer, Breast Cancer, Prostate Cancer, Head and Neck Cancer, Other Applications], By End-user [Hospitals, Ambulatory Surgical Centers, Cancer Care Centers], By Region, Opportunities and Forecast, FY2018-FY2032F

India radiotherapy devices market is projected to grow at a CAGR of 7.00% from FY2025 to FY2032, increasing from USD 412.22 million in FY2024 to USD 708.27 million by FY2032. The market for radiotherapy devices in India is growing due to an increase in the cancer burden, indigenous manufacturing, technological advancements, and public-private partnerships. 

The Indian radiotherapy devices market is expanding as new cancer cases are growing, healthcare expenditure is rising, and the government is taking initiatives to enhance cancer care. The booming economy and rapidly growing middle-class population in the nation have resulted in huge investments in adopting advanced healthcare technologies. Moreover, the motivation for the achievement of self-sufficiency in the production of medical equipment with strong indigenous capabilities is to reduce the dependence on imports. Strong public-private partnerships are making it easy to establish advanced treatment centers. Also, the increasing awareness of screening and early cancer detection further results in rising demand for radiotherapy services. The country's aspirations to position itself as a global healthcare hub create the need to equip the country with advanced radiotherapy equipment, which would prove indispensable in supplying quality cancer care and placing the country competitively in the international market.

Furthermore, the expansion of healthcare centers, such as specialized centers of cancer and radiation therapy facilities, enhances the availability and accessibility of radiotherapy equipment. For instance, in April 2024, Lady Hardinge Medical College, located in New Delhi, inaugurated and treated its first cancer patient with brachytherapy equipment. This treatment is provided for patients suffering from some kinds of cancers and other diseases. With more facilities being set up, this will increase accessibility to radiotherapy services, hence increasing the demand for radiotherapy devices in further treatment of patients.

Increasing Cancer Burden Influencing India Radiotherapy Devices Market Growth

The rising burden of cancer cases in India is resulting in a higher demand for radiotherapy devices, which, in turn, leads to the expansion of the radiotherapy devices market. The alarming increase in cancer cases in India, which gets worsened by significantly delayed diagnoses resulting in higher mortality rates along with lower recoveries, necessitates raising public awareness and educational awareness among professionals to address this significant issue. Predictive and precision medicine, and integrated AI diagnostics, provide further hope to tackle this issue. The demand for radiotherapy devices is expected to significantly increase as diagnostic methods become more common and affordable. Increasingly systematic screening programs focusing on prevalent cancers, as well as on high-risk individuals, are essential. Risk identification and improvement of data sharing constitute part of the government's digital health initiatives. Collaboration between the public and private sectors is of utmost importance in adequately dealing with the growing burden of cancer. Such interaction will promote demand for better-advanced radiotherapy technologies that improve patient care and outcomes. Public-Private Partnerships (PPPs) have significantly increased access to cancer care in India. For example, Varian Medical Systems, Inc. has partnered with the Central and State Governments to establish radiation therapy centers in public hospitals. The government provides the infrastructure, while private operators supply the equipment and services at agreed-upon prices for the benefit of patients.

Increasing Government Initiatives to Drive the Radiotherapy Devices Market Growth

The government has initiated various schemes and policies to encourage growth in the medical devices market, particularly radiotherapy equipment. The Make in India initiative supports the domestic manufacturing of medical devices, including those used in cancer treatment, to reduce import dependency. Moreover, in the Production Linked Incentive Scheme (PLI) scheme, incentives are proposed for specific cancer care technologies, including advanced radiotherapy technologies.

Such developments allow growth and innovation for the medical industry in India, which, in turn, attracts investments that help research institutions develop technology to increase the adoption of advanced medical devices in health facilities. In this case, with growing awareness about treatments for cancer treatment, more patients will look at the need for advanced therapies, increasing device demand and promoting the Indian radiotherapy devices market progression. For instance, in June 2024, Apollo Cancer Centres partnered with Accuray Medical Equipment India Pvt. Ltd., to introduce India's first Robotic Stereotactic Radiotherapy Program. It will provide advanced training for radiation oncologists, physicists, and technicians in Chennai and Bangalore locations. This program will feature hands-on training and in-depth discussions to enhance local medical education, providing improved cancer care using the Cyberknife system.

Developments in Technology to Propel India Radiotherapy Devices Market Growth

With the increase in cancer cases, there is an emerging demand for advanced technologies in treatment, especially among late-stage cancers that are challenging to treat. The rise in cancer cases in India highlights the market for an advanced and affordable healthcare system covering cancer care so that anyone can easily approach cancer care. Innovations in radiotherapy from key players in the healthcare sector are involved in improving comfort for cancer patients. Many hospitals and medical facilities have embraced these innovations. Advanced treatment techniques used include proton therapy, precision radiation therapies such as intensity-modulated radiation therapy, and image-guided radiation therapy. For instance, in August 2024, Sahyadri Hospitals Private Limited installed the TomoTherapy Radixact X9 system with VitalHold technology. This radiotherapy solution has unfolded new dimensions in treating cancer by providing precision, significantly when tumors are affected by patient movement. It is the first installation in Asia with the system and features Auto Beam Hold, which will cease radiation if the patient moves beyond safe limits. Advanced imaging capabilities significantly improve the detection and accuracy of treatment in tumors, hence elevating patient care.

Hospitals to Hold Substantial Market Share

Hospitals in India account for a relatively more significant share of the radiotherapy devices market due to the increasing patient requirements for cancer treatment, technological advancements, and government initiatives towards healthcare infrastructure development. Their capability to provide comprehensive care invests in modern equipment that enhances the quality of service delivered. This trend accelerates market growth, attracts further investments in innovations, and brings about healthy competition among the manufacturers, which results in better accessibility and affordability of radiotherapy services amongst patients located in various parts of the country. Therefore, hospitals are increasingly installing such advanced radiotherapy devices in their facility to improve patient outcomes. For instance, in April 2024, the Swami Rama Himalayan University (SRHU) Cancer Research Institute (Himalayan Hospital) installed the Halcyon B Linear Accelerator for radiotherapy at the Himalayan Hospital. With cancer cases on a leap and bound in India, this high-end machine will enhance the present treatment portfolio of the patients. Being the first private teaching hospital in Uttarakhand wielding this technology, Himalayan Hospital would ensure the pain of the side effects among its affected patients is not so grueling during treatment and, hence, bring a highly positive change.

Download Free Sample Report

Future Market Scenario (FY2025 –FY2032F)

Technologically advanced elements, such as precision radiation therapy, integration of AI for treatment planning, and new technologies like proton therapy, will drive the Indian market for radiotherapy devices. Major companies are stressing cost-effective solutions and are enhancing patient care through personalized treatment approaches. In September 2024, Accuray Medical Equipment India Pvt. Ltd (Accuray) unveiled its CE-marked Accuray Helix system in India. The CT-guided helical radiotherapy system will provide high performance and efficiency, reaching into emerging markets where advanced cancer care, including radiotherapy is often limited to urban areas with fewer facilities such as a linear accelerator.

Report Scope

“India Radiotherapy Devices Market Assessment, Opportunities and Forecast, FY2018-FY2032F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of India radiotherapy devices market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between FY2025 and FY2032. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Report Attribute	Details
Base Year of the Analysis	FY2024
Historical Period	FY2018-FY2023
Forecast Period	FY2025-FY2032
Projected Growth Rate	CAGR of 7.00% between FY2025 and FY2032
Revenue Forecast in FY2032	USD 708.27 million
Segments Covered	Product, Application, End-user
Regions Covered	North, South, East, West and Central
Key Companies Profile	Elekta Medical Systems India Pvt. Ltd., Accuray Medical Equipment India Pvt. Ltd., Koninklijke Philips N.V., Ion Beam Applications S.A., Vision RT Ltd., BEBIG Medical GmbH, Mitsubishi Electric India Pvt. Ltd., Varian Medical Systems, Inc., Society for Applied Microwave Electronics Engineering & Research, Brainlab India Pvt. Ltd.
Customization Scope	15% free report customization with purchase
Pricing and Purchase Options	Avail the customized purchase options to fulfill your precise research needs
Delivery Format	PDF and Excel through email (subject to the license purchased)

In the report, India radiotherapy devices market has been segmented into the following categories: 

• By Product
  • External Beam Radiation Therapy Devices
    • Advanced Linear Accelerators
      • Gamma Knife
      • Cyberknife
      • TomoTherapy
      • MRI LINAC
    • Conventional Linear Accelerators
    • Conventional Cobalt-60 Teletherapy Units
    • Proton Therapy Devices
      • Cyclotrons
      • Synchrotron
      • Synchrocyclotron
    • Internal Beam Radiation Therapy Devices
      • Brachytherapy Devices
      • Consumables
    • Others
  • By Application
    • Lung Cancer
    • Breast Cancer
    • Prostate Cancer
    • Head and Neck Cancer
    • Other Applications
  • By End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Cancer Care Centers
  • By Region
    • North
    • South
    • East
    • West and Central

Key Players Landscape and Outlook

Major players in India radiotherapy devices market are building their presence through partnerships with government hospitals, increasing the distribution outreach, and investing in local manufacturing. It includes improving access to best-in-class cancer treatment and resultant gains to strengthen their competitive position in the market.

In November 2023, Elekta AB (Elekta) received an order worth USD 40 million from Krishna Institute of Medical Sciences (KIMS) in Hyderabad. The order includes cutting-edge equipment like the Elekta Unity MR-Linacs and Leksell Gamma Knife systems, which will enable KIMS to deliver more personalized cancer treatments and enhance the care of their patients while minimizing side effects.

In July 2023, Elekta AB (Elekta) collaborated with GE HealthCare Technologies Inc., intending to scale up accessibility to precise radiation therapy in India. Through this agreement, these companies will ensure that complete systems for imaging and treatment are delivered to hospitals, providing radiation therapy to cancer patients and, hence, improving the care of patients.

Key Players Operating in India Radiotherapy Devices Market are:

• Elekta Medical Systems India Pvt. Ltd.
• Accuray Medical Equipment India Pvt. Ltd.
• Koninklijke Philips N.V.
• Ion Beam Applications S.A.
• Vision RT Ltd.
• BEBIG Medical GmbH
• Mitsubishi Electric India Pvt. Ltd.
• Varian Medical Systems, Inc.
• Society for Applied Microwave Electronics Engineering & Research
• Brainlab India Pvt. Ltd.

Markets and Data report answers the following questions:

• What is the current and future market size of the product/service in question globally or specific to different countries?
• How are the markets divided into different product/service segments and the market size and growth of each segment?
• What is the market potential of different product segments and their investment case?
• How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
• What is the business environment and regulatory landscape specific to the product/service?

If you can't find what you're searching for or have any custom requirements for India radiotherapy devices market, you may approach our team at info@marketsandata.com